Glen Ventures is a venture capital firm dedicated to investing globally in early-stage healthtech.

Backing Visionary Entrepreneurs to Reshape Healthcare Through Technology

Glen Ventures is a venture capital firm dedicated to investing globally in early-stage healthcare technology companies.

Get In Touch


Our Mission

At Glen Ventures, our mission is clear: to invest in health technology companies with the potential to achieve global growth and deliver transformative impact. We champion Lifechanging Launches that redefine the future of healthcare, partnering with visionary entrepreneurs to turn groundbreaking ideas into reality.

Our commitment goes beyond capital—we Empower Entrepreneurs with the knowledge, resources, and connections they need to succeed. Through our Nurturing Network, we cultivate a collaborative ecosystem that accelerates innovation and fosters meaningful connections, enabling ideas to flourish and reach their full potential. Together, we strive to actively shape the future of healthcare, driving sustainable solutions that improve lives worldwide.

At Glen Ventures, we don’t just invest in healthcare innovation—we help create it, one transformative launch at a time.

Join Our Mission
]

Portfolio



Team

Michael Goodman
Founding Partner

in

Samuel Ohayon
Managing Partner

in


Our pillars—Global Growth, Lifechanging Launches, Empowering Entrepreneurs, and Nurturing Network—form the foundation of Glen Ventures' mission, driving our efforts to shape the future of healthcare and create meaningful, lasting change.

Get In Touch

Global Growth

At Glen Ventures, we strategically invest in healthtech companies with the potential for Global Growth and market impact. Leveraging a global network and sharp market insights, we source top-tier opportunities and partner with exceptional entrepreneurs to scale transformative innovations. Our focus is on delivering value by identifying high-growth markets, enabling world-class deal flow, and driving measurable outcomes. With a commitment to advancing cutting-edge solutions, we aim to maximize returns while shaping the future of healthcare on a global scale.

Lifechanging Launches

At Glen Ventures, Lifechanging Launches are at the core of our vision. We invest in healthtech startups and innovations with the capacity to reshape healthcare delivery, elevate patient outcomes, and transform lives. Our focus is on bold ideas that offer breakthroughs, not just incremental progress, addressing critical gaps in care and unlocking new possibilities in health and wellness. By providing strategic support and resources, we accelerate the journey from concept to market, enabling solutions that revolutionize treatments, enhance accessibility, and personalize care. Every launch we back is a step toward redefining the future of healthcare.

Empowering Entrepreneurs

At Glen Ventures, Empowering Entrepreneurs is central to our mission. We recognize that every transformative innovation begins with a visionary entrepreneur. Beyond providing capital, we offer mentorship, strategic guidance, and access to a global network of industry experts to help navigate the complexities of healthcare. Our goal is to equip entrepreneurs with the tools and support they need to succeed—not just in their current ventures, but as future leaders in healthcare innovation. By empowering bold thinkers, we drive progress and build the foundation for lasting impact in the industry.

Nurturing Network

At Glen Ventures, our Nurturing Network is the backbone of our strategy—a dynamic and ever-expanding community of investors, industry leaders, healthcare professionals, and entrepreneurs working together to advance healthcare innovation. By fostering collaboration, sharing expertise, and building strategic connections, we empower startups to overcome challenges and thrive. This network amplifies the impact of every venture we support, accelerating the journey from groundbreaking ideas to market-ready solutions that drive transformative change in healthcare.



Media

MONTREAL, July 2, 2025 (Newswire.com)
Landmark Study in the Lancet Digital Health: Sensifai's AI Predicts Acute Systemic Inflammation With 90% Sensitivity

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to transform care

MONTREAL, July 2, 2025 (Newswire.com)
Backing the Future of Preemptive Health: Glen Ventures Leads Investment in Sensifai Health

Sensifai emerges from stealth with a landmark peer-reviewed study in The Lancet Digital Health, validating its world-first AI platform to detect inflammatory events before symptoms, redefining how and when care begins.

February 26, 2025
Paperplane Therapeutics raises $1.5 million to ease anxious patients with VR gaming

Funding to help company expand its reach across North America and Europe.

Montreal, February 10, 2025
Paperplane Therapeutics Raises $1.5M to Transform Anxiety and Pain Management with Medical Virtual Reality

Funding Led by Glen Ventures with Significant Support from the Government of Quebec

December 19, 2024
Glen Ventures lands $5 million CAD from IQ fund to back early-stage healthtech startups

VC firm to raise dedicated fund in new year separate from government mandate.



Collaborating Partners



Contact Us

In Person

5100 Blvd. De Maisonneuve Ouest, Suite 608 Montreal, QC Canada H4A 3T2